Mydecine Innovations Group Inc (MYCOF)

Currency in USD
0.0065
+0.0010(+18.25%)
Closed·
MYCOF Scorecard
Full Analysis
Stock generally trades with high price volatility
Earnings results expected in 14 days
Fair Value
Day's Range
0.00650.0065
52 wk Range
0.00070.0115
Key Statistics
Prev. Close
0.0055
Open
0.0065
Day's Range
0.0065-0.0065
52 wk Range
0.0007-0.0115
Volume
946
Average Volume (3m)
4.9K
1-Year Change
-13.75%
Book Value / Share
-0.18
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYCOF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Mydecine Innovations Group Inc Company Profile

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005 a family of psilocin analogs. The company also develops MYCO-006 a family of MDMA analogs and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Compare MYCOF to Peers and Sector

Metrics to compare
MYCOF
Peers
Sector
Relationship
P/E Ratio
2.5x−2.5x−0.5x
PEG Ratio
0.020.020.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
-0.7x3.3x
Upside (Analyst Target)
-0.0%45.1%
Fair Value Upside
Unlock15.9%7.4%Unlock

Earnings

Latest Release
Jul 09, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MYCOF Income Statement

FAQ

What Stock Exchange Does Mydecine Innovations Group Inc Trade On?

Mydecine Innovations Group Inc is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Mydecine Innovations Group Inc?

The stock symbol for Mydecine Innovations Group Inc is "MYCOF."

What Is the Mydecine Innovations Group Inc Market Cap?

As of today, Mydecine Innovations Group Inc market cap is 400.17K.

What Is Mydecine Innovations Group Inc's Earnings Per Share (TTM)?

The Mydecine Innovations Group Inc EPS (TTM) is 0.00.

When Is the Next Mydecine Innovations Group Inc Earnings Date?

Mydecine Innovations Group Inc will release its next earnings report on 17 Aug 2025.

From a Technical Analysis Perspective, Is MYCOF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Mydecine Innovations Group Inc Stock Split?

Mydecine Innovations Group Inc has split 2 times.

How Many Employees Does Mydecine Innovations Group Inc Have?

Mydecine Innovations Group Inc has 0 employees.

What is the current trading status of Mydecine Innovations Group Inc (MYCOF)?

As of 04 Aug 2025, Mydecine Innovations Group Inc (MYCOF) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.00 to 0.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.